Hector Perez’s kidney cancer journey
March 14, 2023
This is a guest post by Hector Perez, a KCA Ambassador. It’s been 12 years since I was diagnosed with…
Read More
Below, we’ve linked highlights from research presented at IKCS 2020, the KCA’s fall symposium, which took place on November 6-7, as well as selections from the KCA’s first annual Virtual Patient Symposium on November 7.
Treatments differ in rare versus more common kidney cancers – Targeted Oncology
Selecting appropriate treatments for patients with unresectable kidney cancer – Targeted Oncology
Dr. Brian Rini on choosing between IO/IO or IO/TKI combinations in mRCC – OncLive TV
Dr. Ulka Vaishampayan on the expanding role of TKI/Immunotherapy combinations in mRCC – OncLive TV
Dr. Bradley McGregor on the potential utility of cabozantinib/nivolumab in advanced RCC – OncLive TV
March 14, 2023
This is a guest post by Hector Perez, a KCA Ambassador. It’s been 12 years since I was diagnosed with…
Read More
March 13, 2023
This is a guest post by Frances Mora, 39. Frances lives in Miami. We are quickly approaching the one-year mark,…
Read More
March 8, 2023
This is a guest post by Rachel O’Leary. In March of 2022 I was going to see my orthopedist for…
Read More